The Intersection of COVID-19 and Chronic Lung Disease: Treating Real World Issues with Evolving Data

Released On
August 20, 2020

Expires On
August 20, 2021

Media Type
Internet

Completion Time
90 minutes

Specialty
Critical Care, Primary Care, Pulmunology

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by National Jewish Health.

 

This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Registered Nurses — 1.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

Pulmonologists, critical care physicians, primary care physicians, internal medicine physicians, physician assistants, advanced practice nurses, and registered nurses who treat patients with COVID-19 and/or chronic lung disease.

Overview

According to the American Lung Association, more than 35 million Americans live with a chronic lung disease and may be more susceptible to COVID-19. Severe disease is a higher risk for patients with asthma, COPD, pulmonary fibrosis and other chronic lung disease. Learn how to best manage these patients in the time of COVID-19 from expert faculty who will describe the key concepts in the pathophysiology and immunology of COVID-19, address the latest treatment options for patients with COVID-19 and how chronic lung disease factors into treatment strategies as well as how to manage those patients even after COVID-19.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe clinical features and key concepts in the pathophysiology of COVID-19 and its interaction with the human immune response.
  • Discuss strategies for managing patients with COVID-19 and chronic lung disease.
  • Evaluate current and emerging therapies for patients with COVID-19 and chronic lung disease.

Faculty

Anthony N. Gerber, MD, PhD

Anthony N. Gerber, MD, PhD

Professor of Medicine
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Biomedical Research
National Jewish Health
Denver, CO

Rebecca C. Keith, MD

Rebecca C. Keith, MD

Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
Autoimmune Lung Center
National Jewish Health
Denver, CO

Joshua J. Solomon, MD

Joshua J. Solomon, MD

Associate Chief, Section of Critical Care
Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

National Jewish Health designates this enduring educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 1.5 nursing contact hours.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties. All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Disclosures

Anthony N. Gerber, MD, PhD discloses he is a consultant for BeiGene, Pliant Therapeutics, BioScience Pharma, and Apellis Pharmaceuticals.

Rebecca C. Keith, MD discloses she is a speaker for Boehringer Ingelheim and Genentech.

Joshua J. Solomon, MD discloses he is a speaker for Genentech and receives research funding from NIH, Pfizer, and Boehringer Ingelheim.

Planners and Reviewers

Amy Olson, MD, MSPH discloses that she is on an advisory board, a speaker and conducts research for Boehringer Ingelheim. She is also a speaker for Genentech, PeerView, and Vindico as well as on the Board of Directors for MedGraphics.

Mandy Comeau has no financial relationships to disclose.

Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.

Lauren Rieck has no financial relationships to disclose.

Deborah A. Fending, RN, BSN, AE-C has no financial relationships to disclose.

James H. Finigan, MD has no financial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.
Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

Disclaimer

National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Privacy Policy

https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices

The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME).

We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.

If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities.